Desnatherapeutics

•mRNA vaccines for autoimmune diseases and severe allergies

‒Stops harmful immune reactions

‒Clinical proof of concept and safety for approach in various indications

‒Platform proof on concept in multiple disease models

•Fast to clinical proof of concept approach for severe peanut allergy

•Large and rapidly growing markets with significant unmet needs

•Experienced team with multiple exits